Delivery Order SPE2DR25D1106-SPE2DR26FJD2M
- Not listed
- The Defense Logistics Agency awarded a $10,145 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed price contract type. This delivery order, with an ultimate completion date of December 12, 2025, represents a child award under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, issued September 2, 2025, with completion targeted for September 23, 2025, represents a firm fixed-price procurement with no set-aside designation. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of...
- The Defense Logistics Agency awarded a delivery order valued at $2,938.28 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,784.38 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of September 25, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $6,287.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of October 27, 2025. This competitive award, issued on October 24, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vaccine delivery will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $2,676.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, issued on November 13, 2025, with completion by November 14, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,406.00 for Rabavert rabies vaccine with diluents, with performance at the company's facility in Conshohocken, Pennsylvania. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 5, 2025. The delivery order represents a specific transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,910.10 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 21, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award is issued as a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,095.80 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order operates under a firm fixed price structure and represents a discrete transaction within AmerisourceBergen's broader...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJD2MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,174.00 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of December 12, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The rabies vaccine delivery supports DLA's pharmaceutical supply mission to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's substantial IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. The company's federal contracting history demonstrates consistent capability in fulfilling competitively awarded medical supply requirements across multiple therapeutic domains, with delivery orders ranging significantly in value and scope.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 12/10/25 |